Newspaper publication dated 14 August 2025, of the Unaudited Financial Results of the Company for the quarter ended 30th June, 2025.
BROOKS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Brooks Laboratories Limited has submitted to BSE and NSE the newspaper cuttings of its unaudited standalone and consolidated financial results for Q1 FY26 (quarter ended 30 June 2025), published in Financial Express (all editions) and Jansatta (Chandigarh edition) on 14 August 2025. This filing is a routine compliance under Regulation 47 of SEBI's Listing Obligations and Disclosure Requirements (LODR) Regulations, 2015. The financial numbers themselves are embedded in the scanned newspaper clippings and are not legibly extractable from the text of the filing. No management commentary, guidance, or material deviation was disclosed in the intimation letter.
This is a standard regulatory disclosure with no direct impact on the stock price. It simply confirms that Brooks Labs has met its quarterly results publication requirement on time. Investors should look at the actual financial results (separately filed with the exchanges) to assess the company's Q1 performance.